申请人:E. R. Squibb & Sons, Inc.
公开号:US04104467A1
公开(公告)日:1978-08-01
Compounds having the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein R.sub.1 is hydrogen, halogen, trifluoromethyl, alkyl, alkoxy, nitro, amino, or hydroxy; and R.sub.2 is an amino group, a 5- or 6-membered heterocyclic group, a 3-indolyl group, carboxyl, or alkoxycarbonyl; and n is 0, 1, 2, 3, 4 or 5; have antiinflammatory activity.
具有以下公式##STR1##及其药学上可接受的盐,其中R.sub.1为氢、卤素、三氟甲基、烷基、烷氧基、硝基、氨基或羟基;而R.sub.2为氨基、5-或6-成员杂环基、3-吲哚基、羧基或烷氧羰基;n为0、1、2、3、4或5;具有抗炎活性。